Open clinical trial data for all? A view from regulators.

by Hans-Georg Eichler, Eric Abadie, Alasdair Breckenridge, Hubert Leufkens, Guido Rasi
Published 2012-01-01

The use of surrogate endpoints in regulating medicines for cardio-renal disease: opinions of stakeholders.

by Bauke Schievink, Hiddo Lambers Heerspink, Hubert Leufkens, Dick De Zeeuw, Jarno Hoekman
Published 2014-01-01

Companies’ Health Technology Assessment Strategies and Practices in Australia, Canada, England, France, Germany, Italy and Spain: An Industry Metrics Study

by Ting Wang, Ting Wang, Neil McAuslane, Lawrence Liberti, Helga Gardarsdottir, Wim Goettsch, Wim Goettsch, Hubert Leufkens
Published 2020-12-01

Identification of a Set of Patient-Related Features to Foster Safe Prescribing of Specific Antipsychotics in the Elderly With Dementia

by João Pedro Aguiar, João Pedro Aguiar, Catarina Bernardo, João Gama Marques, João Gama Marques, Hubert Leufkens, Filipa Alves da Costa, Filipa Alves da Costa
Published 2020-10-01